Janux Therapeutics, Inc. (JANX)
17.84
+0.02
(+0.11%)
USD |
NASDAQ |
Nov 04, 14:47
Janux Therapeutics Market Cap : 1.090B for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 1.088B |
| November 02, 2026 | 1.066B |
| October 30, 2026 | 1.067B |
| October 29, 2026 | 1.089B |
| October 28, 2026 | 1.102B |
| October 27, 2026 | 1.054B |
| October 26, 2026 | 1.019B |
| October 23, 2026 | 1.018B |
| October 22, 2026 | 1.042B |
| October 21, 2026 | 1.034B |
| October 20, 2026 | 1.051B |
| October 19, 2026 | 1.022B |
| October 16, 2026 | 1.008B |
| October 15, 2026 | 1.058B |
| October 14, 2026 | 1.046B |
| October 13, 2026 | 1.049B |
| October 12, 2026 | 1.109B |
| October 09, 2026 | 1.123B |
| October 08, 2026 | 1.130B |
| October 07, 2026 | 1.095B |
| October 06, 2026 | 1.025B |
| October 05, 2026 | 1.010B |
| October 02, 2026 | 1.034B |
| October 01, 2026 | 1.036B |
| September 30, 2026 | 1.055B |
| Date | Value |
|---|---|
| September 29, 2026 | 1.035B |
| September 28, 2026 | 1.013B |
| September 25, 2026 | 995.57M |
| September 24, 2026 | 1.019B |
| September 23, 2026 | 1.009B |
| September 22, 2026 | 1.067B |
| September 21, 2026 | 1.039B |
| September 18, 2026 | 1.013B |
| September 17, 2026 | 1.030B |
| September 16, 2026 | 992.21M |
| September 15, 2026 | 1.004B |
| September 14, 2026 | 1.057B |
| September 11, 2026 | 1.044B |
| September 10, 2026 | 1.080B |
| September 09, 2026 | 1.181B |
| September 08, 2026 | 1.224B |
| September 04, 2026 | 1.236B |
| September 03, 2026 | 1.209B |
| September 02, 2026 | 1.203B |
| September 01, 2026 | 1.154B |
| August 31, 2026 | 1.113B |
| August 28, 2026 | 1.101B |
| August 27, 2026 | 1.147B |
| August 26, 2026 | 1.154B |
| August 25, 2026 | 1.141B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Iovance Biotherapeutics, Inc. | 3.932B |
| Agenus, Inc. | 295.11M |
| Amgen, Inc. | 257.84B |
| Anika Therapeutics, Inc. | 274.35M |
| BioCryst Pharmaceuticals, Inc. | 2.091B |
Market Cap Related Metrics
| PS Ratio | 46.42 |
| Price to Book Value | 1.174 |
| Price | 17.84 |
| Earnings Yield | -9.21% |